Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Gains from Investment Securities (2020 - 2024)

INVO Fertility (IVF) has disclosed Gains from Investment Securities for 5 consecutive years, with $507129.0 as the latest value for Q4 2024.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $507129.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$4534.0, a N/A change, with the full-year FY2024 number at -$4534.0, changed N/A from a year prior.
  • Gains from Investment Securities was $507129.0 for Q4 2024 at INVO Fertility, up from $50000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.5 million in Q3 2022 to a low of -$561663.0 in Q1 2024.
  • A 5-year average of $252470.1 and a median of $70412.0 in 2020 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: surged 1609.28% in 2022, then crashed 70307.88% in 2024.
  • INVO Fertility's Gains from Investment Securities stood at -$1062.0 in 2020, then soared by 325.52% to $2395.0 in 2021, then soared by 61678.91% to $1.5 million in 2022, then plummeted by 92.39% to $112628.0 in 2023, then soared by 350.27% to $507129.0 in 2024.
  • Per Business Quant, the three most recent readings for IVF's Gains from Investment Securities are $507129.0 (Q4 2024), $50000.0 (Q2 2024), and -$561663.0 (Q1 2024).